TITLE

EVALUAREA SCCA VERSUS AFP ÃŽN DIAGNOSTICUL PRECOCE AL HEPATOCARCINOMULUI

PUB. DATE
July 2010
SOURCE
Jurnalul de Chirurgie;2010, Vol. 6 Issue 3, p237
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
56642049

 

Related Articles

  • AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. Beale, Gary; Chattopadhyay, Dipankar; Gray, Joe; Stewart, Stephen; Hudson, Mark; Day, Christopher; Trerotoli, Paolo; Giannelli, Gianluigi; Manas, Derek; Reeves, Helen // BMC Cancer;2008, Vol. 8, Special section p1 

    Background: The incidence and mortality of hepatocellular cancer (HCC) complicating alcoholic and non-alcoholic fatty liver diseases (ALD and NAFLD) is rising in western societies. Despite knowing the at risk populations for HCC development, the lack of sensitive and specific means of...

  • Clinical Significance of Plasma Osteopontin Level as a Biomarker of Hepatocellular Carcinoma. Salem, Mona; Abdel Atti, Sahar; El Raziky, Maisa; Kamal Darweesh, Samar; El Sharkawy, Marwa // Gastroenterology Research;Oct2013, Vol. 6 Issue 5, p191 

    Background: Biomarkers of hepatocellular carcinoma (HCC) are helpful in screening, diagnosis and follow up of cases. Osteopontin (OPN) is a glycoprotein secreted by osteoblasts, osteoclasts, macrophages and T cells, and is over-expressed in a variety of tumors, including carcinomas of liver,...

  • Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary. Mizejewski, Gerald J. // Cancer Immunology, Immunotherapy;Feb2009, Vol. 58 Issue 2, p159 

    The various immunological roles of human alpha-fetoprotein (HAFP), and its correlation with hepatomas, that is, hepatocellular carcinomas (HCCs), are not often addressed together in biomedical reports considering that HAFP is an established biomarker for hepatomas. Studies reporting measurement...

  • Perspectives on a combined test of multi serum biomarkers in China: Towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Keming Zhang; Peipei Song; Jianjun Gao; Gaohua Li; Xin Zhao; Shaogeng Zhang // Drug Discoveries & Therapeutics;Jun2014, Vol. 8 Issue 3, p102 

    China has 50% of the worldwide hepatocellular carcinoma (HCC) cases, and the HBV-related cases accounts for approximately 85%. Over the past few decades, although a series of standardized management methods for HCC has been implemented in China, most HCC patient in China still suffered from...

  • FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma. Higashi, Tatsuya; Hatano, Etsuro; Ikai, Iwao; Nishii, Ryuichi; Nakamoto, Yuji; Ishizu, Koichi; Suga, Tsuyoshi; Kawashima, Hidekazu; Togashi, Kaori; Seo, Satoru; Kitamura, Koji; Takada, Yasuji; Kamimoto, Shinji // European Journal of Nuclear Medicine & Molecular Imaging;Mar2010, Vol. 37 Issue 3, p468 

    To elucidate the prognostic role of post-therapeutic 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET), we conducted a retrospective cohort study analysing the clinical factors that affect overall survival after non-operative therapy for unresectable hepatocellular carcinoma...

  • High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma. Kumada, Takashi; Toyoda, Hidenori; Tada, Toshifumi; Kiriyama, Seiki; Tanikawa, Makoto; Hisanaga, Yasuhiro; Kanamori, Akira; Tanaka, Junko; Kagebayashi, Chiaki; Satomura, Shinji // Journal of Gastroenterology;Mar2014, Vol. 49 Issue 3, p555 

    Background: Prognosis of patients with hepatocellular carcinoma (HCC) remains poor because HCC is frequently diagnosed late. Therefore, regular surveillance has been recommended to detect HCC at the early stage when curative treatments can be applied. HCC biomarkers, including Lens culinaris...

  • Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Jirun, Peng; Zhang, Guoxin; Kim, Hyun Kee; Ha, Seon-Ah; Zhongtian, Jin; Shishi, Qiao; Zhuqingqing, Cui; Lei, Gong; Yoo, Jinah; Kim, Sanghee; Park, Yong Gyu; Wang, Jing; Yang, Yang; Xu, Zekuan; Huang, Zuhu; Lee, Yun Kyung; Song, Eun Young; Kim, Jin Woo // Disease Markers;2011, Vol. 30 Issue 6, p307 

    Serum alpha fetoprotein (AFP) is the most widely used tumor marker in detecting patients with hepatocellular carcinoma (HCC). However, it has been indicated that HCCR-1 (human cervical cancer oncogene 1) might be supplementary to AFP in the detection. We conducted a prospective study in 120...

  • Serological biomarkers of hepatocellular carcinoma in Egyptian patients. El-Tayeh, Sarmad F.; Hussein, Tarek D.; El-Houseini, Motawa E.; Amer, Mahmoud A.; El-Sherbini, Mamdooh; Elshemey, Wael M. // Disease Markers;2012, Vol. 32 Issue 4, p255 

    Hepatocellular carcinoma (HCC) is one of the most aggressive cancers worldwide. In Egypt, the disease is usually detected in an advanced stage at which no treatment may be effective including surgery. Early detection of the disease is thus an important goal allowing the patient to be treated...

  • Current clinical uses of the biomarkers for hepatocellular carcinoma. Jiwei Huang; Yong Zeng // Drug Discoveries & Therapeutics;Apr2014, Vol. 8 Issue 2, p98 

    Hepatocellular carcinoma (HCC) is a severe condition that is found worldwide. The current methods of HCC screening and diagnosis depend mainly on tumor imaging techniques. Using tumor biomarkers to detect cancer has helped to screen for disease and avoid wasting medical resources. Serum...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics